Patents by Inventor Marian T. Nakada

Marian T. Nakada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
    Publication number: 20120058128
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: November 9, 2011
    Publication date: March 8, 2012
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Anti-integrin antibodies, compositions, methods and uses
    Patent number: 8071333
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: December 6, 2011
    Assignee: Centocor, Inc.
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Anti-integrin antibodies, compositions, methods and uses
    Patent number: 8071729
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: December 6, 2011
    Assignee: Centocor, Inc.
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
    Publication number: 20090217392
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: April 21, 2009
    Publication date: August 27, 2009
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Anti-Integrin Antibodies, Compositions, Methods and Uses
    Publication number: 20090191117
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 30, 2009
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Anti-integrin antibodies, compositions, methods and uses
    Patent number: 7550142
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: June 23, 2009
    Assignee: Centocor, Inc.
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Emmprin antagonists and uses thereof
    Publication number: 20090028862
    Abstract: EMMPRIN (Extracellular Matrix Metalloproteinase Inducer) antagonists, such as antibodies, including specified portions or variants, siRNA, shRNA, antisense and DNAzymes, can be used to treat pathological processes associated with proliferative diseases, such as cancer, by specifically preventing or inhibiting the ability of proliferating tissue to develop a blood supply.
    Type: Application
    Filed: September 29, 2005
    Publication date: January 29, 2009
    Inventors: Gregory M. Arndt, Mehnaaz Lomas, Marian T. Nakada, Laurent P. Rivory, Yi Tang, Li Yan
  • Anti-integrin antibodies, compositions, methods and uses
    Patent number: 7163681
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: January 16, 2007
    Assignee: Centocor, Inc.
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada
  • Anti-integrin antibodies, compositions, methods and uses
    Publication number: 20040185507
    Abstract: The present invention relates to at least one novel anti-alpha-V subunit antibodies, including isolated nucleic acids that encode at least one anti-alpha-V subunit antibody, alpha-V subunit, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: November 24, 2003
    Publication date: September 23, 2004
    Inventors: Jill Giles-Komar, Linda Snyder, Mohit Trikha, Marian T. Nakada